Recruiting

WaterWorks® Douching Device

Sponsor:

Abbott Research Group

Code:

NCT00417365

Conditions

Vaginal Odor

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

WaterWorks Douching Device

Study Details

Brief summary:

Comparing the new Stainless Steel WaterWorks® douching device to a commercially available douching device using just water for safety and efficacy of odor abatement.

Conditions

Vaginal Odor

Study ID

NCT00417365

Start date

Aug, 2006

Status verified date

Aug, 2007

Completion date

Sep, 2007

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

Enrollment in the study will be open to those subjects who meet the following inclusion criteria:

1. Non-pregnant females, 18 years and older
2. Complaint of abnormal vaginal odor with or without complaints of discharge
3. Subject with perceived, abnormal vaginal odor on the date she is evaluated
4. Odor scale 4 cm or greater (using the subject's perception visual analog rating scale of 10 cm): 0 = no odor 10 = strong offensive odor
5. Subject is not fulfilling Amsel's criteria for BV listed below (only meets 0 or 1 Amsel's criteria)
6. Not treated for Bacterial Vaginosis, VVC, intra-vaginal or oral anti-fungal medications or antibiotics, within the last 14 days of enrollment
7. Willing and able to comply with study requirements
8. Has provided written informed consent

Exclusion Criteria:

Subjects will be excluded from the enrollment if they have any of the following:

1. Odor scale less than 4 cm (on the Visual Analog rating scale of 10 cm)
2. Subjects with presence of BV
3. Subjects with other lower genital tract infections (e.g., symptomatic VVC, trichomoniasis, Chlamydia trachomatis, Neisseria gonorrhoeae or herpes simplex virus)
4. Subjects with another vaginal or vulvar condition, which would confound the interpretation of clinical response
5. Subjects who received antifungal or antimicrobial therapy (systemic or intravaginal) within the last 14 days
6. Subjects who will be under treatment during the study period for cervical intra-epithelial neoplasia (CIN) or cervical carcinoma
7. Positive pregnancy test
8. Any abnormal anatomy or pathology of the subject's vagina
9. Known HIV positive
10. Pap smear >LSIL (untreated or not evaluated) \[LSIL = Low-grade squamous intraepithelial lesion\]
11. Subject currently having a menstrual period (excluded until completion of period)
12. Subjects with a body mass index (BMI) of 39 or greater
13. Investigator believes that external factor(s) is producing odor

Study Design

Enrollment

100 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Interventions

WaterWorks Douching Device

Primary outcome measure

  • The primary endpoint of the study is the reduction or abatement of the [ Time Frame: undefined ]
  • subject's perceived vaginal odor as determined at Visit 3. [ Time Frame: undefined ]
  • This improvement will be measured using a visual analog scale that [ Time Frame: undefined ]
  • asks subjects to rate their perception of vaginal odor on a scale that [ Time Frame: undefined ]
  • is anchored at two extremes, "no odor", and, "strong offensive odor". [ Time Frame: undefined ]

Central Contacts and Locations

Locations

Wayne State University, Harper Hospital

Recruiting

Detroit, Michigan, United States, 48201

Contacts

Principal Investigator:

Jack Sobel, M.D.

Salem Research

Recruiting

Winston Salem, North Carolina, United States, 27103

Contacts

Principal Investigator:

Thomas Valaoras, M.D.

Temple University Hospital

Recruiting

Philadelphia, Pennsylvania, United States, 19140

Contacts

Sarminia Hassan, M.D.

215-707-7278shassan@temple.edu

Principal Investigator:

Ashwin Chatwni, M.D.

More Information

Sponsor

Abbott Research Group

Last update posted

Aug 15, 2007

Last verified

Aug, 2007

Keywords

  • odor
  • douching
  • BV
  • vaginitis
  • vaginal
  • yeast
  • ecosystem
  • Lactobacilli
  • Nugent
  • Amsel

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Abbott Research Group on 2007-08-15.